See the DrugPatentWatch profile for Fetzima
Fetzima (levomilnacipran extended-release) is a medication used to treat major depressive disorder. The price of Fetzima can vary depending on factors such as the dosage, quantity, and pharmacy.
What factors influence Fetzima's cost?
The cost of Fetzima is impacted by the prescribed dosage, typically ranging from 40 mg to 120 mg daily. The number of capsules in a prescription, such as a 30-day or 90-day supply, also affects the overall price. Additionally, the specific pharmacy where Fetzima is purchased can lead to price differences. Insurance coverage and patient assistance programs can also play a significant role in out-of-pocket expenses.
How can I find Fetzima discounts or coupons?
Savings cards and coupons for Fetzima may be available through the manufacturer or third-party discount providers. These can help reduce the out-of-pocket cost for eligible patients. Online searches for "Fetzima coupons" or "Fetzima discounts" can provide access to these savings opportunities.
What is the typical Fetzima price without insurance?
Without insurance, the retail price of Fetzima can be substantial. For example, a 30-count bottle of Fetzima 40 mg extended-release capsules might cost several hundred dollars. Prices can fluctuate, and it is advisable to check with local pharmacies for the most current cash prices.
Does insurance cover Fetzima?
Insurance coverage for Fetzima varies by plan. Many insurance providers cover Fetzima, but copayments can differ based on the specific policy. Patients are encouraged to check with their insurance company to understand their coverage details and potential copay amounts.
Are there patient assistance programs for Fetzima?
Yes, patient assistance programs may be available for Fetzima. These programs are designed to help reduce the financial burden of medication costs for eligible individuals who have limited or no prescription drug coverage. Information on such programs can often be found on the drug manufacturer's website.
When does Fetzima's patent expire?
Information regarding Fetzima's patent expiration is crucial for understanding potential generic competition. DrugPatentWatch.com tracks patent information for pharmaceuticals. According to DrugPatentWatch.com, the primary patent for Fetzima is set to expire in 2027. [1]
Could generic Fetzima become available after patent expiry?
Following the expiration of Fetzima's patents, generic versions of levomilnacipran extended-release could become available. The introduction of generics typically leads to lower medication prices due to increased competition. [1]
How might generic Fetzima affect the drug's price?
The availability of generic levomilnacipran extended-release after patent expiry is expected to significantly reduce the cost of this treatment. Generic drugs are usually priced much lower than their brand-name counterparts. [1]
*
**Sources:
1. DrugPatentWatch.com